The path forward for protein footprinting, covalent labeling, and mass spectrometry-based protein conformational analyses.
Nicholas B BorottoPublished in: Journal of mass spectrometry : JMS (2024)
Mass spectrometry-based approaches to assess protein conformation have become widely utilized due to their sensitivity, low sample requirements, and broad applicability to proteins regardless of size and environment. Their wide applicability and sensitivity also make these techniques suitable for the analysis of complex mixtures of proteins, and thus, they have been applied at the cell and even the simple organism levels. These works are impressive, but they predominately employ "bottom-up" workflows and require proteolytic digestion prior to analysis. Once digested, it is not possible to distinguish the proteoform from which any single peptide is derived and therefore, one cannot associate distal-in primary structure-concurrent post-translational modifications (PTMs) or covalent labels, as they would be found on separate peptides. Thus, analyses via bottom-up proteomics report the average PTM status and higher-order structure (HOS) of all existing proteoforms. Second, these works predominately employ promiscuous reagents to probe protein HOS. While this does lead to improved conformational resolution, the formation of many products can divide the signal associated with low-copy number proteins below signal-to-noise thresholds and complicate the bioinformatic analysis of these already challenging systems. In this perspective, I further detail these limitations and discuss the positives and negatives of top-down proteomics as an alternative.
Keyphrases
- mass spectrometry
- copy number
- amino acid
- protein protein
- single molecule
- liquid chromatography
- molecular dynamics simulations
- molecular dynamics
- high resolution
- binding protein
- genome wide
- squamous cell carcinoma
- stem cells
- high performance liquid chromatography
- single cell
- small molecule
- bone marrow
- dna methylation
- risk assessment
- living cells
- gene expression
- rectal cancer
- ionic liquid